Others

Parmax Pharma Ltd - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

| Updated on November 03, 2018 Published on November 03, 2018

PARMAX PHARMA LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2018 ,inter alia, to consider and approve Pursuant to Regulations 29(1)(a) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to notify that a meeting of the Board of Directors of the Company is proposed to be held on Sunday, the 11th November, 2018 at registered office of the Company at 1:00 P.M. to, inter-alia, consider, approve and take on record the Standalone Unaudited Financial Results of the Company for the second quarter and half year ended 30th September, 2018.
Further, the trading window shall remain closed for all designated persons including promoters, directors, key managerial personnel, designated employees and other connected persons of the Company with immediate effect till completion of 48 hours after the Standalone Unaudited Financial Results are submitted to the stock exchanges.

Thanking you.

Pdf Link: Parmax Pharma Ltd - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Source : BSE - www.bseindia.com

Published on November 03, 2018
This article is closed for comments.
Please Email the Editor